Premier backs a device deal: what it means for Premier stock

Published on 10/16/2026 at 02:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Premier members received special terms in a September 28, 2026 device deal. Premier stock traces back to a USD 2.50 billion buyout completed on November 25, 2025.

Healthcare platform and ownership

Tulavi's agreement with Premier took effect on September 15, 2026.
Premier appointed two executives on September 21, 2026, including a chief AI officer with more than 20 years of experience.
Premier's ownership changed through a USD 2.50 billion buyout completed on November 25, 2025.

PINC, US74051N1028, Illustration mit AI erstellt.

Premier backs a new medical-device agreement tied to Tulavi Therapeutics, giving its members access to special pricing and pre-negotiated terms from September 15, 2026. The agreement was reported on September 28, 2026, by PR Newswire.

Three dates shape Premier

Premier's recent path combines leadership, purchasing reach and product access. On May 5, 2026, Premier appointed Emad Rizk as chief executive officer, president and chairman, according to the company's related announcement on its official news page. The Tulavi agreement became effective on September 15, 2026, covering one national group purchasing arrangement. On September 28, 2026, the company was linked to Tulavi's Breakthrough Technology designation for one implantable product, according to PR Newswire.

What does the device deal mean?

The agreement extends Premier's group purchasing role into a specific surgical technology. Tulavi said Premier members could use special pricing and terms for the allay Hydrogel Cap, while Premier's own platform combines supply-chain solutions, data and analytics, and advisory services, according to Premier. Premier says it represents two-thirds of U.S. healthcare providers and has USD 87.0 billion in collective purchasing power.

AI leadership adds a second angle

On September 21, 2026, Premier announced two executive appointments. Florian Quarre became chief AI and analytics officer after more than 20 years in healthcare, artificial intelligence and transformation, while Matthew Zubiller became chief business and product officer after 30 years leading healthcare, technology and services organizations, according to Premier. The appointments connect the device agreement with a broader effort to embed data and artificial intelligence into products and workflows.

Ownership sets the backdrop

Premier's public-market context changed after Patient Square Capital completed a USD 2.50 billion acquisition on November 25, 2025, as reported by Zonebourse. For readers following PINC, the current story is therefore centered on Premier's operating platform and strategic execution rather than a fresh earnings release.

Company details and market context

Premier's healthcare technology model links providers, suppliers and payers through data, analytics, supply-chain solutions and advisory services. Its recent announcements place AI leadership and member purchasing access at the center of that model.